Research News & Funding Opportunities for Tulane Cancer Researchers - June 4, 2024 | |
Chancellor Donald, MD, Assistant Professor of Medicine in the Section of Hematology and Medical Oncology, was recently featured in a Tulane Doctors Medical Minute during the Fox 8 Morning News discussing the importance of family history to cancer risk, detection and treatment. To view the video, click here. | |
|
NSF System Updates in Accordance With Implementation of the Revised Proposal & Award Policies & Procedures Guide (PAPPG)
Effective May 20, 2024, the U.S. National Science Foundation (NSF) made a number of system updates in accordance with implementation of the revised Proposal & Award Policies & Procedures Guide (PAPPG) (NSF 24-1) for proposals submitted or due on or after May 20, 2024.
If you submit or provide administrative support for proposals to the NSF, please familiarize yourself with these updates here.
| |
Tulane Cancer Center Lapel Pins Are Here!
Tulane Cancer Center recently ordered a supply of magnetic branded lapel pins for our members and other representatives to wear proudly at meetings, speaking opportunities and other special events. If you have a meeting or event in the near future, please contact Melanie Cross at mcross@tulane.edu to get yours.
| |
LSU / LCMC Health Cancer Center Faculty Candidate Seminar
Dissecting Genomic Instability: A Driving Force of Cancer
Youwei Zhang, PhD
Professor
Department of Pharmacology
Case Western Reserve University School of Medicine
Wednesday, June 5 - Noon - 1:00 PM
Louisiana Cancer Research Center Auditorium
1700 Tulane Ave., New Orleans
Lunch available at 11:45 AM
Zoom Meeting ID: 980 2919 3437
Passcode: 793033
| | | |
|
LA EPSCoR is now accepting applications for the following programs:
- LAMDA Seed Funding Track 1A: Single Investigator
- LAMDA Seed Funding Track 1B: Collaborative Partnership
- LAMDA Seed Funding Track 1C: Post-Doctoral Research
- LAMDA Seed Funding Track 2: Industrial Collaboration
- LAMDA Seed Funding Track 4: STEM Outreach
Deadline for proposals is Friday, June 7, 2024. Please follow this link to their online submission system -- https://laepscor.piestar-rfx.com/ -- and view the opportunities listed there. The RFPs will also be available on their website, https://rsi.laregents.edu/programs/epscor-programs/.
| |
Tulane Career Development Club Presentation
Charting Your Course: Navigating NIH Grant Reviews and Submissions
Prasad Katakam, MD, PhD
Professor of Pharmacology &
Katherine Mills, PhD, MSPH
Associate Professor of Epidemiology
Monday, June 10 - Noon - 1:00 PM
Diboll Auditorium/Gallery, 1st Floor
Tidewater Building
1440 Canal St., New Orleans
To view the event flier, please click here.
To register, please click here.
| |
School of Medicine Picture Day
Wednesday, June 12 - 9:00 AM - 4:00 PM
Hutchinson, Room 1551
Free to all Tulane School of Medicine faculty, staff, residents, fellows and students.
Sign up for a time here and bring your white coat if you have one.
| |
|
Budget Workshop for
Female Founders
July 15 - 4:00 - 6:00 PM
Salon 22
2407 Bienville St., New Orleans, LA 70119
Salon 22 and Tulane Adjunct Professor Jane Cooper are offering a Budget Workshop for early-stage company founders. The workshop teaches the basics of creating an annual budget, including defining customers, sales and revenue, product/service pricing, volume of sales, cost of goods sold, monthly expenses, and profit/loss. It is a five-week intensive course that ends with a 12-month budget for your company. For more information or to register, click here.
| |
NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
PAR-24-153
APPLICATION DUE DATE: JUNE 18, 2024
The purpose of the NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12) is to support the training of clinical scientists in community cancer prevention, screening, intervention, control, and treatment research. Special emphasis is placed on training clinical scientists whose career goal is to improve the care and outcomes of minority health populations and populations with health disparities that are underrepresented in clinical research by increasing their access to and representation as human subjects in cancer clinical trials using an equity lens.
This Notice of Funding Opportunity (NOFO) allows the appointment of Scholars proposing to serve as the lead investigator of an independent community-based clinical trial; proposing to increase the integration of cancer health disparities research questions into clinical trials; or proposing a separate ancillary study to an existing prevention, screening, intervention, control or treatment trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of minority health populations and populations with health disparities that are underrepresented as human subjects in cancer clinical trials, as part of their research and career development.
| |
|
Forge AHEAD Pilot Grant Opportunity
The Forge AHEAD Program's new pilot grant opportunity -- made available through Tulane's partnership in the UAB Center for Clinical and Translational Science -- provides a 1-year, $50,000 award for applicants interested in conducting clinical, community, and population health research into cardiometabolic diseases. Interested applicants should also include health equity and social determinants of health components in their research plans.
The next deadline for letters of intent is June 25.
This flyer provides additional information, but please contact Andy Barton at abarton1@tulane.edu or 504-988-9038 with any questions or to set up a brief call to discuss how your research might fit this request for applications.
| |
Pfizer Global Medical Grants Announces a New Education RFP in Cervical Cancer
Improving Care for Patients with Recurrent / Metastatic (R/M) Cervical Cancer
The goal of this RFP is to support education for medical oncologists, gynecologic oncologists, pharmacists, eye care providers, nurse practitioners and physician assistants working in the oncology setting caring for patients with r/m cervical cancer relating to treatments, management of adverse events, and long-term outcomes.
To review the full RFP please click here.
Application Due Date: August 22, 2024
Tony Enterante, Senior Development Officer for Corporate, Foundation and Research Relations, is happy to work with applicants on their submissions. You can contact Tony at aenteranteiii@tulane.edu.
| |
Request for Proposals
Equity in Access Research Program
The Leukemia & Lymphoma Society (LLS) has just released a Request for Proposals (RFP) for its Equity in Access Research Program, which is dedicated to funding health services research.
They are reissuing the RFP Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups. Awards will be a maximum of $2.5 million each, over 5 years.
Specifically, they seek proposals that will implement and evaluate interventions designed to:
- Mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups
- Quantitatively measure the impact of these interventions on patient accrual
They are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.
It is not necessary for applicants to have previously conducted research in blood cancer. The due date for Letters of Intent is September 12, 2024 at 2 pm CST.
For more information, visit LLS.org/EquityinAccess
| |
|
Congratulations, Dr. El-Dahr!
Tulane Cancer Center Member Samir El-Dahr, MD, the Jane B. Aron Professor and Chair of the Department of Pediatrics at the School of Medicine and Pediatrician-in-Chief at Children’s Hospital New Orleans, was honored with the prestigious Henry L. Barnett Award at the Pediatric Academic Societies Meeting in Toronto, Canada. The Henry L. Barnett Award recognizes individuals who have made significant contributions to the teaching of nephrology and advocacy for children, and who exemplify distinguished service in the field.
|
|
|
Recent Member Publications | |
|
Imaging modalities during navigational bronchoscopy. Abdelghani R, Omballi M, Abia-Trujillo D, Casillas E Jr, Villalobos R, Badar F, Bansal S, Kheir F. Expert Rev Respir Med. 2024 May 29:1-14. doi: 10.1080/17476348.2024.2359601. Online ahead of print. PMID: 38794918 Review.
Validation of human telomere length multi-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as human telomere length regulation genes. Keener R, Chhetri SB, Connelly CJ, Taub MA, Conomos MP, Weinstock J, Ni B, Strober B, Aslibekyan S, Auer PL, Barwick L, Becker LC, Blangero J, Bleecker ER, Brody JA, Cade BE, Celedon JC, Chang YC, Cupples LA, Custer B, Freedman BI, Gladwin MT, Heckbert SR, Hou L, Irvin MR, Isasi CR, Johnsen JM, Kenny EE, Kooperberg C, Minster RL, Naseri T, Viali S, Nekhai S, Pankratz N, Peyser PA, Taylor KD, Telen MJ, Wu B, Yanek LR, Yang IV, Albert C, Arnett DK, Ashley-Koch AE, Barnes KC, Bis JC, Blackwell TW, Boerwinkle E, Burchard EG, Carson AP, Chen Z, Chen YI, Darbar D, de Andrade M, Ellinor PT, Fornage M, Gelb BD, Gilliland FD, He J, Islam T, Kaab S, Kardia SLR, Kelly S, Konkle BA, Kumar R, Loos RJF, Martinez FD, McGarvey ST, Meyers DA, Mitchell BD, Montgomery CG, North KE, Palmer ND, Peralta JM, Raby BA, Redline S, Rich SS, Roden D, Rotter JI, Ruczinski I, Schwartz D, Sciurba F, Shoemaker MB, Silverman EK, Sinner MF, Smith NL, Smith AV, Tiwari HK, Vasan RS, Weiss ST, Williams LK, Zhang Y, Ziv E, Raffield LM, Reiner AP; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; TOPMed Hematology and Hemostasis Working Group; TOPMed Structural Variation Working Group; Arvanitis M, Greider CW, Mathias RA, Battle A. Nat Commun. 2024 May 24;15(1):4417. doi: 10.1038/s41467-024-48394-y. PMID: 38789417
| |
|
The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.
More Information
| |
Cell Analysis Core
The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.
More Information
| |
Tulane Cancer Center Membership
Please click here for Tulane Cancer Center's membership guidelines and our online application form.
| |
Subscribe to Nexus
If you know someone who is interested in subsribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.
| |
Send Us Your News / Share Your Feedback | |
Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.
| | | | |
